Silverback Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $345k | 34k | 10.05 |
| 2025-06-30 | $572k | 33k | 17.45 |
| 2025-03-31 | $408k | 32k | 12.58 |
| 2024-12-31 | $349k | 33k | 10.55 |
| 2024-09-30 | $425k | 29k | 14.50 |
| 2024-06-30 | $250k | 29k | 8.51 |
| 2023-12-31 | $76k | 14k | 5.48 |
| 2023-09-30 | $52k | 14k | 3.78 |
| 2023-06-30 | $92k | 14k | 6.70 |
| 2021-09-30 | $91k | 9.1k | 10.00 |
| 2021-06-30 | $171k | 5.5k | 30.94 |
| 2021-03-31 | $241k | 5.5k | 43.63 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors